Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P4
Near historical low
vs 2Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -142.83% |
| Q3 2025 | 389.25% |
| Q2 2025 | 23.68% |
| Q1 2025 | -135.29% |
| Q4 2024 | 714.09% |
| Q3 2024 | 24.39% |
| Q2 2024 | 27.24% |
| Q1 2024 | -228.79% |
| Q4 2023 | 219.95% |
| Q3 2023 | 2.44% |
| Q2 2023 | -8.19% |
| Q1 2023 | 2.32% |
| Q4 2022 | -16.32% |
| Q3 2022 | -0.48% |
| Q2 2022 | 25.19% |
| Q1 2022 | -93.37% |
| Q4 2021 | 20.36% |
| Q3 2021 | -31.01% |
| Q2 2021 | 1.69% |
| Q1 2021 | -61.13% |
| Q4 2020 | -24.42% |
| Q3 2020 | -63.60% |
| Q2 2020 | -24.76% |
| Q1 2020 | 0.00% |